Surlux Diagnostic Ltd.
| BSE: 507854 | Sector: Health care |
| NSE: N.A. | ISIN Code: N.A. |
| BSE 05:30 | 01 Jan | Surlux Diagnostic Ltd |
| NSE 05:30 | 01 Jan | Surlux Diagnostic Ltd |
Surlux Diagnostic Ltd. (SURLUXDIAGNO) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 913.70 | 219,224.03 | 12,803.21 | 2,139.70 | 32,510.54 |
| Divi's Lab. | 3,903.90 | 103,629.03 | 8,879.82 | 2,948.54 | 11,718.06 |
| Cipla | 1,028.00 | 82,959.60 | 13,091.79 | 2,957.93 | 22,671.86 |
| Dr Reddy's Labs | 4,222.15 | 70,273.47 | 14,405.20 | 1,623.20 | 20,636.20 |
| Apollo Hospitals | 4,432.95 | 63,736.95 | 6,098.30 | 665.20 | 8,868.60 |
| Torrent Pharma. | 1,558.60 | 52,749.26 | 6,742.32 | 991.45 | 9,910.76 |
| Abbott India | 20,419.10 | 43,390.59 | 4,919.27 | 798.70 | 3,063.88 |
| Piramal Enterp. | 1,805.50 | 43,088.26 | 2,225.68 | 572.28 | 29,038.13 |
| Gland Pharma | 2,325.00 | 38,292.75 | 3,462.88 | 997.01 | 5,909.86 |
| Biocon | 314.25 | 37,728.85 | 1,738.20 | 86.10 | 8,279.00 |
| Zydus Lifesci. | 363.55 | 37,216.61 | 7,981.90 | 857.90 | 16,096.50 |
| Max Healthcare | 383.20 | 37,156.22 | 1,079.68 | -164.45 | 6,439.88 |
| Alkem Lab | 2,969.50 | 35,500.37 | 8,829.81 | 1,541.25 | 11,301.35 |
| Aurobindo Pharma | 570.60 | 33,431.45 | 11,287.14 | 1,454.71 | 19,017.26 |
| Lupin | 664.70 | 30,220.59 | 11,771.67 | -188.70 | 19,439.28 |
| Laurus Labs | 551.65 | 29,642.91 | 4,707.04 | 750.09 | 5,178.13 |
| Ipca Labs. | 1,006.40 | 25,532.37 | 5,399.36 | 870.94 | 6,342.72 |
| Glaxosmi. Pharma | 1,424.45 | 24,131.61 | 3,217.51 | 1,690.53 | 2,948.24 |
| Syngene Intl. | 571.15 | 22,927.67 | 2,601.40 | 393.80 | 4,609.20 |
| Dr Lal Pathlabs | 2,430.00 | 20,254.05 | 1,872.71 | 344.05 | 1,981.58 |
Quick Links for Surlux Diagnostic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
